...
首页> 外文期刊>International journal of infectious diseases : >Comparative efficacy of various antimicrobial lock solutions for preventing catheter-related bloodstream infections: A network meta-analysis of 9099 patients from 52 randomized controlled trials
【24h】

Comparative efficacy of various antimicrobial lock solutions for preventing catheter-related bloodstream infections: A network meta-analysis of 9099 patients from 52 randomized controlled trials

机译:各种抗菌锁定溶液预防导管相关的血流感染的比较功效:来自52个随机对照试验的9099名患者的网络荟萃分析

获取原文
           

摘要

Objectives It remains uncertain which catheter lock solution (CLS) to prevent catheter-related bloodstream infections (CRBSI) works best and is safest for patients. This study was performed to compare the efficacy of different CLSs for the prevention of CRBSI and ranked these CLSs for practical consideration. Methods The PubMed, Web of Science, Embase, and MEDLINE databases, earlier relevant meta-analyses, and the reference lists of included studies were searched. The primary outcome was CRBSI; secondary outcomes were catheter-related thrombosis and exit-site infections. A network meta-analysis was performed to estimate odds ratios (ORs) with 95% confidence intervals (CIs). Results A total of 52 randomized controlled trials involving 9099 patients and evaluating 13 CLSs (single and combinations) were included. With regard to the quality of the evidence, the risk of bias was typically low or unclear (45 out of 52 trials, 86.5%). In the network meta-analysis, saline (OR 8.44, 95% CI 2.19–32.46), gentamicin?+?citrate (OR 2.92, 95% CI 1.32–6.42), ethanol (OR 5.33, 95% CI 1.22–23.32), and cloxacillin?+?heparin (OR 2.07, 95% CI 1.19–5.49) were associated with a greater effect on CRBSI than heparin. Conclusions This network meta-analysis showed that minocycline–ethylenediaminetetraacetic acid (EDTA) seemed to be the most effective for the prevention of CRBSI and exit-site infection, and cefotaxime?+?heparin seemed to be the most effective for catheter-related thrombosis.
机译:目的尚不确定哪种导管锁定溶液(CLS)可以预防导管相关的血流感染(CRBSI)效果最佳,并且对患者最安全。进行这项研究以比较不同CLS预防CRBSI的功效,并对这些CLS进行分级以供实际考虑。方法检索PubMed,Web of Science,Embase和MEDLINE数据库,早期相关的荟萃分析以及纳入研究的参考文献列表。主要结果是CRBSI。次要结果是与导管相关的血栓形成和出口部位感染。进行网络荟萃分析以估计具有95%置信区间(CI)的比值比(OR)。结果总共包括52项随机对照试验,涉及9099名患者并评估了13个CLS(单个或组合)。关于证据的质量,偏倚的风险通常较低或不清楚(52项试验中的45项,占86.5%)。在网络荟萃分析中,盐水(OR 8.44,95%CI 2.19–32.46),庆大霉素+柠檬酸盐(OR 2.92,95%CI 1.32–6.42),乙醇(OR 5.33,95%CI 1.22–23.32),与氯西林+肝素(OR 2.07,95%CI 1.19–5.49)相比,CRBSI的疗效要好于肝素。结论该网络荟萃分析显示,米诺环素-乙二胺四乙酸(EDTA)似乎对CRBSI和出口部位感染的预防最有效,而头孢噻肟+肝素似乎对与导管相关的血栓形成最有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号